Effect of vericiguat on cardiovascular outcomes in patients with heart failure with and without diabetes: Insights from the VICTORIA trial

Back

ESC Professional Premium Access

Effect of vericiguat on cardiovascular outcomes in patients with heart failure with and without diabetes: Insights from the VICTORIA trial

Session: HFrEF pathophysiology

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Professor J. Butler (Dallas, US)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Professor Javed Butler

Baylor Scott & White Health, Dallas (United States of America)

116 presentations

16 followers

6 more presentations in this session

Repetitive LevosimenDan infusions fOR patients with advanced chronic heart failure in the vulnerable post-discharge period: the multinational randomized LeoDOR trial

Speaker: Associate Professor G. Polzl (Innsbruck, AT)

Deep learning model to identify potential occurrence of reduced LVEF in patients with implantable loop recorders

Speaker: Doctor J. Howard (London, GB)

The effect of iron deficiency treatment with intravenous ferric carboxymaltose on the arrhythmic burden of patients with HFrEF and cardiac implantable electronic devices

Speaker: Mr A. Tsarouchas (Thessaloniki, GR)

Prognostic value of three iron deficiency definitions in patients with advanced heart failure

Speaker: Doctor J. Reinhold (Norwich, GB)

Accelerometer-measured physical activity in patients with heart failure and reduced ejection fraction: determinants and relationship with patient-reported health status

Speaker: Doctor J. Larsen (Odense, DK)

Access the full session

HFrEF pathophysiology

Speakers: Professor J. Butler, Associate Professor G. Polzl, Doctor J. Howard, Mr A. Tsarouchas, Doctor J. Reinhold...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources